Pharmaceuticals, Biotechnology and Life Sciences
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, has expanded two additional cohorts from the Phase II SUMMIT…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc., a privately held, clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat…
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced that the European Commission has approved VIZIMPRO® (dacomitinib), a tyrosine kinase inhibitor…
Roche presents data from a mock clinical trial study suggesting that next-generation discovery proteomics is ready for use in clinical…
TORONTO–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/FSDDF?src=hash” target=”_blank”gt;#FSDDFlt;/agt;–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today the appointment…
SAGINAW, Mich.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/NPN?src=hash" target="_blank"gt;#NPNlt;/agt;–Graminex® L.L.C., producer of Graminex® Non-Solvent Flower Pollen Extracts™, receives Health Canada Approval under the Natural…
WALTHAM, Mass.–(BUSINESS WIRE)–Sobi, an international biopharmaceutical company transforming the lives of people affected by rare diseases, announced that investigators will…
TOKYO–(BUSINESS WIRE)–Kyowa Hakko Kirin Co., Ltd. (TOKYO:4151, President and CEO: Masashi Miyamoto, “Kyowa Kirin”) announced that the U.S. Food and…
SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that…
PRIME (PRIority MEdicines) designation based on clinical study results evaluating safety and efficacy of novel CAR-T therapy in the treatment…